Rule lifecycle · DOCKET:DEA-989
Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act
Department of Justice, Drug Enforcement Administration — observed across 5 documents over 1165 days. Use the source documents below before deciding whether this affects your business.
In plain English
The DEA is making five drugs—clonazolam, diclazepam, etizolam, flualprazolam, and flubromazolam—completely illegal to manufacture, sell, or distribute starting April 1, 2026. If your business sells any of these five substances or products containing them, you need to stop immediately to avoid serious federal criminal penalties and fines.
First seen
Dec 23, 2022
Last seen
Mar 2, 2026
Latest stage
Rule
PRORULE → RULE
1165d
Effective on
Wednesday, April 1, 2026
Stage timeline
Proposed·Dec 23, 2022
Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I
effective Dec 23, 2022#2022-27278
Final·Jul 26, 2023
Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I
effective Jul 26, 2023#2023-15748
Final·Jul 25, 2025
Schedules of Controlled Substances: Extension of Temporary Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act
effective Jul 26, 2025#2025-14037
Proposed·Jul 25, 2025
Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act
#2025-14022
Final·Mar 2, 2026
Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act
effective Apr 1, 2026#2026-04112